Nexus Capital Investments, Inc.
CIK: 0002132998
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Nexus Capital Investments, Inc.
Nexus Capital Investments, Inc. (SEC CIK 0002132998) files insider reports with the SEC as 10% Owner of BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH).
Signal8 holds 1 ownership filing by Nexus Capital Investments, Inc., a Form 3, filed on Sep 4, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Nexus Capital Investments, Inc.'s filings is in ATHENS, GA.
Other insiders filing for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
- Mager Scott, Director
- Ferguson Merle, Director
- KAISER RICHARD KAISER, CEO & CFO